97296 ⎘
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Preparation of scFv antibody fragments
#3902Antibodies directed to the receptor tyrosine kinase c-Met
#3903Anti-human transferrin receptor antibody and uses thereof
#3904Antibodies to the B12-transcobalamin receptor
#3905Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II)
#3906LLT-1 antibodies with new functional properties
#3907VEGF/DLL4 binding agents and uses thereof
#3908Substance specific to human PD-1
#3909Antibodies against human angiopoietin 2
#3910Monoclonal antibodies for treatment of cancer
#3911Binding molecules for BCMA and CD3
#3912Binding molecules for BCMA and CD3
#3913Anti-TAT226 antibodies and immunoconjugates
#3914Development of masked therapeutic antibodies to limit off-target effects; application to anti-EGFR antibodies
#3915Compositions and methods for the treatment of tumor of hematopoietic origin
#3916Anti-VEGF antibody compositions and methods
#3917Anti-EGFR antibody and use thereof
#3918Method of Treating Cancer Using a cMET and AXL Inhibitor and an ErbB Inhibitor
#3919Therapeutic use of anti-CD22 antibodies for inducing trogocytosis
#3920Anti-CD74 immunoconjugates and methods of use
#3921Biological materials related to HER3
#3922Pulmonary administration of immunoglobulin single variable domains and constructs thereof
#3923Mutated humanized 12G4 antibodies and the fragments thereof against the human anti-Mullerian hormone receptor type II
#3924Humanized antibodies to iNKT
#3925Interferon lambada-antibody complexes
#3926Highly-functional mutant of humanized anti-EGFR antibody variable region
#3927Neutralizing prolactin receptor antibodies and their therapeutic use
#3928ANTIBODIES TO EGFL7 AND METHODS FOR THEIR USE
#3929Methods for treating cancer by administering an anti-Ang-2 antibody
#3930Antibody against carcinoembryonic antigen and uses thereof
#3931Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodies
#3932Engineered anti-IL-23p19 antibodies
#3933Methods for cancer management targeting Co-029
#3934Human monoclonal antibodies to human nucleolin
#3935Reducer of immunosuppression by tumor cell and antitumor agent using the same
#3936Human CD3-specific antibody with immunosuppressive properties
#3937Heterodimeric proteins and methods for producing and purifying them
#3938Optical dome bezel
#3939Compositions monovalent for CD28 binding and methods of use
#3940Anti-PSGL-1 antibodies and methods of inducing cell death of an activated T cell
#3941TRAIL R2-specific multimeric scaffolds
#3942Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors
#3943Antibody specifically binding to epitope in SEMA domain of c-Met
#3944Anti c-Met humanized antibody and uses thereof
#3945Hybrid constant regions
#3946Antibodies directed to ERBB2
#3947ANTI C-MET ANTIBODY AND USES THEREOF
#3948Anti-clathrin heavy chain monoclonal antibody for inhibition of tumor angiogenesis and growth and application thereof
#3949Anti-ErbB3 antibodies and uses thereof
#3950Anti-HLA-DR Antibodies Suppress Allogeneic and Xenogeneic Immune Responses to Organ Transplants
#3951Bispecific binding molecules binding to VEGF and ANG2
#3952CONJUGATE MOLECULE
#3953Anti B7-H3 antibody
#3954Monoclonal antibodies for treatment of cancer
#3955ENHANCED DEATH RECEPTOR AGONISTS
#3956Humanized anti-EGFL7 antibodies and methods using same
#3957Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof
#3958Development of masked therapeutic antibodies to limit off-target effects
#3959COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#3960Anti-S1P antibody treatment of patients with ocular disease
#3961Novel Modulators and Methods of Use
#3962Antigenic GM-CSF peptides and antibodies to GM-CSF
#3963BOVINE POLYCLONAL ANTIBODY SPECIFIC FOR HUMAN TNF
#3964Bispecific antigen binding molecules
#3965Antibodies to tumor endothelial marker 7R
#3966ANTI-VEGF ANTIBODIES
#3967Method for the treatment of T cell mediated conditions by depletion of ICOS-positive cells in vivo
#3968Antibodies that bind OV064 and methods of use therefor
#3969NOVEL ANTI-CD98 ANTIBODY AND USE THEREOF
#3970ANTI-PROSTATE CANCER ANTIBODIES AND METHODS OF DETECTION AND TREATMENT OF PROSTATE CANCER USING THE SAME
#3971Antibodies and pharmaceutical compositions thereof which bind urokinase-type plasminogen activator receptor (uPAR)
#3972Fully human monoclonal antibody to VEGF, preparation method and use thereof
#3973Anti-FGFR3 antibodies and methods using same
#3974MUC1 antibody
#3975Methods for the Treatment of an Infectious Bacterial Disease with an Anti-Lactone or Lactone Derived Signal Molecules Antibody
#3976ANTIBODIES DIRECTED AGAINST THE TRANSFERRIN RECEPTOR AND USES THEREOF FOR IMMUNOTHERAPY OF IRON-DEPENDENT TUMOURS
#3977ANTI-PD-L1 ANTIBODIES AND ARTICLES OF MANUFACTURE
#3978METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION TO TREAT TUMOR IMMUNITY
#3979METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO TREAT INFECTION RESULTING FROM T-CELL DYSFUNCTION
#3980ANTIBODIES THAT BIND TO PSCA PROTEINS FOR DIAGNOSIS OF CANCER
#3981ANTI-HUMAN INTERLEUKIN-20 ANTIBODIES
#3982Anti-EFGRv3 monoclonal antibody
#3983Diagnostic and therapeutic target
#3984Engineered anti-IL-23p19 antibodies
#3985Siglec 15 antibodies in treating bone loss-related disease
#3986Heterodimeric antibody Fc-containing proteins and methods for production thereof
#3987Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
#3988METHODS OF TARGETING CELLS FOR DIAGNOSIS AND THERAPY
#3989Adenocarcinoma specific antibody SAM-6, and uses thereof
#3990Antibodies and methods of using same for treating ErbB/ErbB ligands associated diseases
#3991USE FOR PRODUCTION OF THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR OSTEOARTHRITIS
#3992Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers
#3993TREATMENT OF TRAUMATIC BRAIN INJURY USING ANTIBODIES TO LYSOPHOSPHATIDIC ACID
#3994Methods and compositions for modulation of Olfml3 mediated angiogenesis
#3995Humanized anti CXCR4 antibodies for the treatment of cancer
#3996Rodent combinatorial antibody libraries
#3997Antibodies to the NOTCH1 receptor
#3998VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
#3999Human antibodies that bind mesothelin, and uses thereof
#4000Human antibodies that bind mesothelin, and uses thereof
#4001Human antibodies that bind mesothelin, and uses thereof
#4002Semaphorin 3C (Sema3C) inhibitor therapeutics, methods, and uses
#4003Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
#4004Humanization of rabbit antibodies using a universal antibody framework
#4005Method for Cloning Cognate Antibodies
#4006Nucleic acids encoding humanized anti-CD40 antibodies
#4007Antibodies that specifically bind to TIM3
#4008NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE
#4009Trivalent, bispecific antibodies
#4010Antibodies directed to GPNMB and uses thereof
#4011DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS
#4012FTY720 increases CD74 expression and sensitizes cancer cells to anti-CD74 antibody-mediated cell death
#4013OVR115 ANTIBODY COMPOSITIONS AND METHODS OF USE
#4014Anti-IL-6 antibodies
#4015Methods of making and using multispecific antibody panels and antibody analog panels
#4016Multivalent fibronectin based scaffold domain proteins
#4017Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
#4018Antagonist anti-CD40 monoclonal antibodies and methods for their use
#4019COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#4020Methods For Inducing Autolysis In Infectious Bacteria
#4021Antibodies against human CSF-1R
#4022Nucleic acid encoding antibody to human IL-22
#4023Engineered anti-TSLP antibody
#4024Engineered anti-TSLP antibody
#4025ANTI-NGF ANTIBODIES FOR THE TREATMENT OF VARIOUS DISORDERS
#4026Monoclonal antibodies that bind B7H6 and uses thereof
#4027Antibodies against human CSF-1R
#4028Antigen binding sites to non-functional oligomeric P2X7 receptors and methods of use thereof
#4029Means for the diagnosis and therapy of CTCL
#4030Methods of treating cancer using Notch1 and Notch3 antagonists
#4031Camptothecin-binding moiety conjugates
#4032Compositions and Methods for Treating Inflammatory Lung Disease
#4033Anti-VEGF antibodies
#4034Methods for enhancing anti-tumor antibody therapy
#4035NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE
#4036Antibodies against G-CSFR and uses thereof
#4037HEPATOCYTE GROWTH FACTOR RECEPTOR ANTAGONISTS AND USES THEREOF
#4038Bispecific anti-VEGF/anti-ANG-2 antibodies
#4039Methods and compositions for inhibiting CD32B expressing cells
#4040ANTI-C4.4A ANTIBODIES AND USES THEREOF
#4041Antibodies to c-Met
#4042CRYSTAL STRUCTURES AND METHODS USING SAME
#4043Method for inhibiting platelet derived growth factor signaling with C3aR or C5aR antibodies
#4044NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE
#4045Fully humanized anti-HER2 antibody, preparation method and use thereof
#4046IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS
#4047Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody
#4048Human antibodies that bind human interleukin-12
#4049Antibodies specific for claudin 6 (CLDN6)
#4050COILED COIL AND/OR TETHER CONTAINING PROTEIN COMPLEXES AND USES THEREOF
#4051Podocalyxin-like-protein-1 binding antibody molecule
#4052Jagged-binding agents and uses thereof
#4053Reagents and treatment methods for autoimmune diseases
#4054Compounds
#4055DAC HYP COMPOSITIONS AND METHODS
#4056Radioimmunoconjugates and uses thereof
#4057NUCLEIC ACIDS ENCODING ANTI-IL-23 ANTIBODIES
#4058Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation
#4059Endoglin antibodies
#4060Antagonists of IL-17A, IL-17F, and IL-23P19
#4061Monomeric Bi-Specific Fusion Protein
#4062METHODS OF TREATING CANCER USING IL-21
#4063Antibodies reactive with B7-H3 and uses thereof
#4064METHODS OF TREATING INFLAMMATION USING SOLUBLE IL-17RA/RC FUSION PROTEINS
#4065Methods of treatment by administering antibodies to notch receptors
#4066Anti-IL-12/IL-23 antibodies and uses thereof
#4067Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides
#4068ANTI-NEOPLASTIC USES OF ARTEMIN ANTAGONISTS
#4069Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
#4070PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT
#4071Multivalent Immunoglobulin-Based Bioactive Assemblies
#4072CD37-binding molecules and immunoconjugates thereof
#4073Methods of treating and preventing colitis involving IL-13 and NK-T cells
#4074MULTISPECIFIC MODULAR ANTIBODY
#4075METHODS OF TREATMENT UTILIZIING BINDING PROTEINS OF THE INTERLEUKIN-21 RECEPTOR
#4076Antigenic determinants of human death receptor DR5
#4077Polynucleotides encoding anti-CD100 antibodies or antigen-binding fragments thereof
#4078METHODS OF MODULATING THE OX40 RECEPTOR TO TREAT CANCER
#4079NEUROTROPHINS AND USES THEREOF
#4080Methods and compositions for the treatment of proliferative and pathogenic diseases
#4081Monoclonal antibodies against gonadotropin-releasing hormone receptor
#4082INTERLEUKIN-21 RECEPTOR BINDING PROTEINS
#4083CD40 ANTIBODY FORMULATION AND METHODS
#4084Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
#4085c-Met antibodies
#4086Combination therapy of an afucosylated CD20 antibody with fludarabine and/or mitoxantrone
#4087Antibodies Directed to Angiopoietin-1 and Angiopoietin-2 and Uses Thereof
#4088Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolution
#4089Anti-fibroblast activation protein antibodies and methods and uses thereof
#4090ANTIBODIES AGAINST HUMAN CCN1 AND USES THEREOF
#4091FDF03 ANTIBODIES AND USES THEREOF
#4092Antibodies that bind TGF-alpha and epiregulin
#4093Dual Variable Domain Immunoglobulins and Uses Thereof
#4094Treatment of tumors using specific anti-L1 antibody
#4095METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF THYROID CANCER
#4096GalNAc-SPECIFIC BINDING MOLECULES AND USES THEREOF
#4097Combination immunotherapy for the treatment of cancer
#4098Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof
#4099Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
#4100ANTI-ALPHA V BETA 6 ANTIBODIES
#4101Antibody Fc variants
#4102Human anti-IL-23 antibodies, compositions, methods and uses
#4103Human antibodies that bind the P40 subunit of human IL-12 and methods for using the same
#4104ANTIBODIES TO M-CSF
#4105Biological materials related to c-Met
#4106BISPECIFIC BINDING AGENTS TARGETING IGF-1R AND ERBB3 SIGNALLING AND USES THEREOF
#4107CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS
#4108Treatment of cancer involving mutated KRAS or BRAF genes
#4109COMBINATION THERAPY OF CANCER WITH ANTI-ENDOGLIN ANTIBODIES AND ANTI-VEGF AGENTS
#4110ANTIBODY CAPABLE OF RECOGNIZING HLA CLASS I
#4111CsPCNA isoform antibodies and uses thereof
#4112Modified antibody constant regions
#4113Multivalent antibodies and uses therefor
#4114Compositions and methods relating to anti-IGF-1 receptor antibodies
#4115VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS AND USES THEREOF
#4116Anti-NKG2A antibodies and uses thereof
#4117PREVENTIVES/REMEDIES FOR CANCER
#4118Humanized antibodies against human IL-22RA
#4119Methods for treating conditions associated with c-fms
#4120Non-naturally occurring T cell receptors
#4121Methods of treatment using anti-human IL-21 monoclonal antibodies
#4122Method for inducing cell death in acute lymphoblastic leukemic system cells
#4123Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in VIVO
#4124Engineered anti-TSLP antibody
#4125Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
#4126De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
#4127Methods of modulating immune function
#4128Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use
#4129COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#4130Methods of treatment by administering antibodies that bind colony stimulating factor 1 receptor (CSF1R)
#4131Anti-IL13 antibodies and uses thereof
#4132Methods and compositions for the diagnosis and treatment of thyroid cancer
#4133Amatoxin-Armed Tartget-Binding Moieties for the Treatment of Cancer
#4134Methods of treatment using human antibodies that bind IL-12
#4135Method of treating cancer with antibodies against long-form leukotriene B4 receptor BLT2
#4136Notch1 binding agents and methods of use thereof
#4137Cytokine zalpha11 ligand
#4138Poly-n-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#4139ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION
#4140CD22 Exon 12 Deletion Mutants
#4141Anti-CεmX antibodies capable of binding to human mIgE on B lymphocytes
#4142Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#4143Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#4144HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING
#4145Antibodies that specifically bind to the EphA2 receptor
#4146APRIL ANTAGONISTS AND METHODS OF USE
#4147Immunological compositions as cancer therapeutics
#4148Compositions monovalent for CD28 binding and methods of use
#4149Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
#4150Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
#4151Compositions and methods of use for therapeutic antibodies
#4152Cripto blocking antibodies and uses thereof
#4153Antibodies against a proliferating inducing ligand (APRIL) and methods of use thereof
#4154Anti-alpha5/beta1 antibody
#4155METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
#4156Compositions and Methods for Binding Lysophosphatidic Acid
#4157TRI-VARIABLE DOMAIN BINDING PROTEINS AND USES THEREOF
#4158Human domain antibodies against components of the human insulin-like growth factor (IGF) system
#4159Fusion Protein of an Anti-CD20 Antibody Fab Fragment and Lidamycin, a Method for Preparing the Same, and the Use Thereof
#4160Monoclonal antibodies against claudin-18 for treatment of cancer
#4161Preparation of isolated agonist anti-EDAR monoclonal antibodies
#4162Bifunctional polypeptides
#4163Nanoparticle Based Immunological Stimulation
#4164Methods for Treating or Preventing Malaria by Administering an Antibody that Specifically Binds Angiopoietin-2 (Ang-2)
#4165Bispecific EGFRvIII x CD3 antibody engaging molecules
#4166SUPERIOR EFFICACY OF CD37 ANTIBODIES IN CLL BLOOD SAMPLES
#4167COMPOSITIONS AND METHODS FOR POTENTIATING INTERLEUKIN-35
#4168Vaccine targeting cellular death receptor DR5
#4169DR5—FAP bispecific death receptor agonistic antibodies
#4170DNA encoding antibody molecules having specificity for human IL-6
#4171Fully human antibodies to BTLA
#4172KIDNEY DISEASE TARGETS AND USES THEREOF
#4173COMPOSITIONS AND METHODS COMPRISING VEGFR-2 AND VEGFR-3 ANTAGONISTS FOR THE TREATMENT OF METASTATIC DISEASE
#4174Cancer Metastasis Inhibitor
#4175Methods, compositions and apparatuses for facilitating regeneration
#4176Compositions and methods of use for therapeutic antibodies
#4177Specific binding proteins and uses thereof
#4178Receptor activator of NF-kappaB
#4179Nucleic acid encoding apoptotic anti-IgE antibodies
#4180ANTI-TGF-BETA RECEPTOR II ANTIBODIES
#4181Anti-human IL-21 monoclonal antibodies
#4182Method of treatment and agents useful for same
#4183ANTIGEN-BINDING PROTEINS
#4184Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
#4185CARBOHYDRATE-CONTAINING PAN CANCER MARKER
#4186Methods of using apoptotic anti-IGE antibodies
#4187Meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof
#4188Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin
#4189High affinity antibodies that neutralize enterotoxin B
#4190METHODS OF TREATING HER2 POSITIVE CANCER WITH HER2 RECEPTOR ANTAGONIST IN COMBINATION WITH MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN
#4191Binding members for interleukin-4 receptor alpha (IL-4Ra) - 173
#4192ANTI-HLA-E ANTIBODIES, THERAPEUTIC IMMUNOMODULATORY ANTIBODIES TO HUMAN HLA-E HEAVY CHAIN, USEFUL AS IVIG MIMETICS AND METHODS OF THEIR USE
#4193Monoclonal antibodies against claudin-18 for treatment of cancer
#4194Anti-IL13 antibodies and uses thereof
#4195Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives
#4196Humanized anti-CD47 antibody
#4197DETECTION AND QUANTITATION OF URINE GELSOLIN
#4198Methods and compositions for inhibiting CD32B expressing cells
#4199NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER
#4200EGFR-binding molecules and immunoconjugates thereof